ANI PHARMACEUTICALS INC - 10-Q Filing
ANI Pharmaceuticals filed its Q1 2026 10-Q report with the SEC, disclosing financial results for January to March 2026. The filing includes details on sales of Cortrophin Gel and other pharmaceutical products but does not provide specific revenue or EPS figures in this excerpt.
Tickers: $ANIP